New recommendations regarding IUDs

The APP recently issued a policy statement recommending use of Long Acting Reversible Contraceptives (LARC) as first-line options for adolescents who choose not to be abstinent. LARCs include intrauterine devices and subdermal implants. Growing research over the last decade has shown these devices to be safe for use in teens. LARCs provide between 3 and 10 years of contraception and are considerably more effective at preventing pregnancy than oral contraceptive pills. Some forms of LARC are also approved for heavy menstrual bleeding.

If you’d like more information on this topic, see the American Academy of Pediatrics press release.

A Letter from Dr. Botsford

After more than 40 years dedicated to pediatrics, Dr. Botsford has decided to retire at the end of this year. We announce this with mixed emotions. First and foremost, the entire PCOR family wishes him health and happiness in his retirement! Click here to read his fond farewell letter. We will miss you dearly, Dr. Botsford!!

New Communication Tool Available For Office Visits!

We now offer a system called CHADIS to help us provide your family with a more complete analysis of your child’s health and development. CHADIS stands for Child Health And Development Interactive System. It is a way you can communicate securely with your provider over the internet before your office visit. You can easily use CHADIS on a computer, tablet, or mobile phone. For more information about how to sign up, see the new CHADIS (please hyperlink to appropriate page) section on our website.

9-valent HPV vaccine now available with a NEW ADMINISTRATION SCHEDULE

Gardasil 9 was licensed for use in females and males in December 2014, and is now part of the routine vaccination schedule recommended by the CDC and AAP. It covers 9 strains of the human papillomavirus. This includes HPV 16 and 18- types that cause 66% of cervical cancers and the majority of other cancers in females and males, including anal cancer. Additionally, it covers 5 other cancer-causing strains and 2 strains that cause anogenital warts.

UPDATE: If started before age 15, HPV9 is now given in a series of 2 shots separated by 6 months, even if the 2nd shot falls after the 15th birthday. If you have already received 2 shots separated by at least 6 months and the first was given before your 15th birthday, you are considered fully vaccinated. If you have received 2 shots but they were separated by less than 6 months, you need a third and final vaccine. If you have any questions, please call our office and speak to a nurse about your specific situation.

HPV9 can be used to continue or complete a series started with older HPV vaccines. If you missed your follow up appointments, it is recommended to continue the series at any time. There is no indication to start the series over. In studies, antibody titers were not diminished in patients who waited longer than standard intervals between vaccines in the series.

HPV-9 is recommended for girls and boys ages 11-12 years old. Teen boys and girls who did not get the vaccine when they were younger should get it now. CDC recommends that preteens complete the HPV vaccine 2 shot series by age 13. HPV vaccine produces a higher immune response in preteens than it does in older teens.

HPV frequently asked questions